The company signed a strategic cooperation agreement with Wuhan Fuxing Biopharmaceutical Co., LTD. The two sides will jointly promote the research and development of new products and new technologies and the industrialization and commercialization of new drug products through joint/joint research project topics, technical cooperation/support, joint declaration projects and other forms.
      Based on the principles of independence, resource complementarity and mutual promotion, the two parties shall establish product research and development institutions (laboratories) with their own characteristics. The two parties will strengthen cooperation in intellectual property rights, share patent information, jointly apply for product patents, and provide paid scientific and technological information, scientific and technological services and technical training to the other party according to the requirements of the other party. When needed, Fuxing Biopharmaceutical can be used as the company's research product production base and production training base for technical personnel.
      Wuhan Fuxing Biopharmaceutical Co., Ltd. is a wholly-owned subsidiary of Hubei Fuxing Group Holding Co., LTD. It is a high-tech enterprise integrating drug research and development, production and sales, and is the "advanced enterprise" in Hubei Province's pharmaceutical industry, the "Top ten Innovative Enterprises" in Hubei Province's pharmaceutical industry, and the "Top 50 Pharmaceutical Industry in Hubei Province".